Early diagnosis significantly improves treatment outcomes. Techniques such as imaging modalities (MRI, CT scans), biomarker detection (e.g., PSA for prostate cancer), and liquid biopsies are essential. Developing non-invasive methods to detect circulating tumor DNA (ctDNA) or exosomes in the blood can lead to earlier and more accurate diagnoses.
